Hepion Pharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: CTRVP · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: HEPA
TL;DR
Hepion Pharma (HEPA) filed an 8-K for a shareholder vote - details TBD.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on June 12, 2025, to report on matters submitted to a vote of its security holders. The filing does not disclose specific details of the vote or the outcomes, but it is a standard procedural filing.
Why It Matters
This filing indicates that Hepion Pharmaceuticals held a shareholder vote, which could be related to corporate governance, financing, or strategic decisions that may impact the company's future direction.
Risk Assessment
Risk Level: low — This is a routine procedural filing and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36856 (file_number) — SEC File Number
- 46-2783806 (tax_id) — IRS Employer Identification No.
- 55 Madison Ave Suite 400- PMB# 4362 Morristown , New Jersey 07960 (address) — Principal executive offices
- (732) 902-4000 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Hepion Pharmaceuticals' security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 12, 2025.
What is Hepion Pharmaceuticals, Inc.'s state of incorporation?
Hepion Pharmaceuticals, Inc. is incorporated in Delaware.
What is the principal executive office address for Hepion Pharmaceuticals, Inc.?
The principal executive offices are located at 55 Madison Ave Suite 400- PMB# 4362 Morristown, New Jersey 07960.
Does this 8-K filing provide any financial results or operational updates?
No, this 8-K filing is specifically for reporting matters submitted to a vote of security holders and does not contain financial results or operational updates.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).